Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Invesco Nasdaq Biotechnology ETF (IBBQ) and T. Rowe Price Health Care ETF (TMED) belong to the same industry segment: US Health Care. IBBQ's top 3 sector exposures are Health Care and Consumer Staples. In contrast, TMED's top sector exposures are Health Care and Financials. IBBQ is less expensive with a Total Expense Ratio (TER) of 0.19%, versus 0.44% for TMED. IBBQ is up 3.54% year-to-date (YTD) with +$8M in YTD flows. TMED performs worse with 0.13% YTD performance, and +$3M in YTD flows. Run a side-by-side ETF comparison of IBBQ and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IBBQ TMED | -0.23%+1.16% | +3.22%+1.57% | +3.54%+0.13% | +33.90%n/a | +50.91%n/a | n/an/a |
| Flows | IBBQ TMED | +$2M+$1M | +$13M+$4M | +$8M+$3M | +$21M- | +$41M- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IBBQ TMED | +19.87%+16.57% | +22.98%n/a | +19.25%n/a | n/an/a |
| Max drawdown | IBBQ TMED | -4.51%-7.14% | -17.24%n/a | -23.78%n/a | n/an/a |
| Max drawdown duration | IBBQ TMED | 15d47d | 127dn/a | 375dn/a | n/an/a |
IBBQ | TMED | |
Last sale 3/11/2026 at 7:59 PM | $29.38 | $29.06 |
| Previous close 03/11/2026 | $29.56 | $29.57 |
| Consolidated volume 03/11/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
IBBQ | TMED | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
IBBQ | TMED | |
|---|---|---|
| Last price | $29.38 | $29.06 |
| 1D performance | -0.61% | -1.75% |
| AuM | $74.04 M | $19.32 M |
| E/R | 0.19% | 0.44% |
IBBQ | TMED | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Invesco | T. Rowe Price |
| Benchmark | NASDAQ Biotechnology Index | - |
| N° of holdings | 196 | 74 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 9, 2021 | June 11, 2025 |
| ESG | No | No |
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
Join J.P. Morgan’s Bram Kaplan, Head of Americas Equity Derivatives Strategy and Matt Kaufman from Calamos Investments as they dive into the growing global opportunity in autocallable income—an increasingly dominant strategy within structured products, now available through ETFs.
Accepted for 1 CE Credit
